Raymond James Financial’s DexCom DXCM Stock Holding History

Raymond James Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174M	Buy	2,782,627 +330,415	+13%	+$23M	0.05%	320
2025 Q4	$163M	Sell	2,452,212 -889,408	-27%	-$57.5M	0.05%	329
2025 Q3	$225M	Sell	3,341,620 -37,496	-1%	-$2.97M	0.07%	245
2025 Q2	$295M	Buy	3,379,116 +24,059	+0.7%	+$1.89M	0.1%	185
2025 Q1	$229M	Buy	3,355,057 +631,088	+23%	+$51.5M	0.09%	215
2024 Q4	$212M	Buy	+2,723,969	New	+$202M	0.08%	224

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Raymond James Financial's DXCM Position: Q1 2026 in Review

Raymond James Financial increased its DexCom (DXCM) stake by 13% in Q1 2026, buying an estimated $23M and bringing the position to 2,782,627 shares worth $174M. The position accounts for 0.05% of the portfolio, ranked #320.

Raymond James Financial first reported a position in DXCM in Q4 2024 and has held it in 6 quarters since. The position peaked at $295M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Raymond James Financial held 2,782,627 shares of DexCom worth $174M as of Q1 2026.
Raymond James Financial bought 330,415 DexCom shares in Q1 2026, an estimated $23M.
DexCom made up 0.05% of Raymond James Financial's portfolio in Q1 2026, its #320 holding.
Raymond James Financial first reported a position in DexCom in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's DexCom position peaked at $295M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.